.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

The Role and Rationale for Oral Options in the Treatment of Metastatic Breast Cancer

EP. 1: Treatment Advances in Metastatic Breast Cancer

January 19th 2021

EP. 2: Long-Term Disease Control in Metastatic Breast Cancer

January 19th 2021

EP. 3: Cytotoxic Chemotherapy for Metastatic Breast Cancer

January 19th 2021

EP. 4: Assessing Response to Chemotherapy in Metastatic Breast Cancer

January 19th 2021

EP. 5: Metastatic Breast Cancer: Chemotherapy Selection

January 26th 2021

EP. 6: Predicting Response to Chemotherapy in Metastatic Breast Cancer

January 26th 2021

EP. 7: Chemotherapy to Treat MBC: Drug Developments

February 2nd 2021

EP. 8: Advantages of Oral Therapy for Metastatic Breast Cancer

February 2nd 2021

EP. 9: At-Home Administration of Therapies to Treat MBC

February 9th 2021

EP. 10: Metastatic Breast Cancer Therapy: OPE

February 9th 2021

EP. 11: MBC Therapy: Tesetaxel/Capecitabine

February 16th 2021

EP. 12: Oral Therapies and Dose Reductions in MBC

February 16th 2021

EP. 13: Using Oral Therapies to Advance Care in MBC

February 16th 2021